2C-T-13

From Wikipedia, the free encyclopedia
Jump to: navigation, search
2C-T-13
2C-T-132DACS.svg
2C-T-13-3d-sticks.png
Names
IUPAC name
2-[4-(Methoxyethylthio)-2,5-dimethoxyphenyl]ethanamine
Identifiers
207740-30-5 N
3D model (Jmol) Interactive image
ChEMBL ChEMBL123868 YesY
ChemSpider 21106228 YesY
Properties
C13H21NO3S
Molar mass 271.38 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

2C-T-13 or 2,5-dimethoxy-4-(β-methoxyethylthio)phenethylamine is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL (Phenethylamines i Have Known And Loved).

Chemistry[edit]

2C-T-13 is the 2 carbon homologue of Aleph-13. The full chemical name is 2-[4-(2-methoxyethylthio)-2,5-dimethoxyphenyl]ethanamine. The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21.

General information[edit]

The dosage range of 2C-T-13 is typically 25 - 40 mg and its duration is approximately 6–8 hours according to Shulgin. 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion.[1]

Pharmacology[edit]

The mechanism that produces 2C-T-13's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.

Dangers[edit]

The toxicity of 2C-T-13 is not well documented. 2C-T-13 is slightly less potent than 2C-T-7, but it may be expected that at higher doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.

Legality[edit]

2C-T-13 is not illegal in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

As of October 31st, 2016; 2C-T-13 is a controlled substance (Schedule III) in Canada.[2]

References[edit]

External links[edit]